Old Web
English
Sign In
Acemap
>
authorDetail
>
A Skerjanec
A Skerjanec
Pharmacokinetics
Pharmacodynamics
Pharmacology
Biosimilar
Medicine
4
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
307 Population pharmacokinetic and pharmacodynamic modeling of bevacizumab and a proposed biosimilar (GP2019) in healthy male volunteers
2015
European Journal of Cancer
M. Elmeliegy
E. Potocka
D. Renard
S. Kakar
A Skerjanec
Y. Li
H Castro
M. Izquierdo
D. Barker
Show All
Source
Cite
Save
Citations (1)
Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys
2015
mAbs
Sherri Dudal
K Subramanian
Thierry Flandre
Ws Law
Philip J. Lowe
A Skerjanec
J-C Genin
M. Duval
A Piequet
A Cordier
G Jarai
G Van Heeke
Sarah Taplin
Carsten Krantz
S Jones
Andrew Paul Warren
Frank R Brennan
Jennifer Sims
Peter Lloyd
Show All
Source
Cite
Save
Citations (11)
Mechanisms of nonlinear pharmacokinetics of mibefradil in chronically instrumented dogs.
1996
Journal of Pharmacology and Experimental Therapeutics
A Skerjanec
S. Tawfik
Yun K. Tam
Show All
Source
Cite
Save
Citations (8)
1